Cytokinetics, Inc. (CYTK)
65.60
-0.02
(-0.03%)
USD |
NASDAQ |
Oct 02, 16:00
65.59
-0.01
(-0.02%)
After-Hours: 20:00
Cytokinetics Price : 65.60 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 66.45 | 66.91 | 64.49 | 65.60 | 2.650M |
| Oct 01, 2026 | 65.73 | 67.27 | 65.30 | 65.62 | 1.724M |
| Sep 30, 2026 | 65.90 | 66.92 | 65.25 | 65.91 | 2.978M |
| Sep 29, 2026 | 65.91 | 66.52 | 64.38 | 65.64 | 2.402M |
| Sep 28, 2026 | 64.58 | 66.41 | 64.25 | 66.16 | 2.551M |
| Sep 25, 2026 | 65.66 | 65.94 | 64.44 | 64.66 | 1.599M |
| Sep 24, 2026 | 65.37 | 66.47 | 64.89 | 65.66 | 1.837M |
| Sep 23, 2026 | 67.02 | 67.38 | 64.72 | 65.81 | 2.051M |
| Sep 22, 2026 | 68.07 | 69.56 | 67.48 | 67.59 | 2.389M |
| Sep 21, 2026 | 69.30 | 69.50 | 67.35 | 67.56 | 1.603M |
| Sep 18, 2026 | 70.18 | 70.18 | 68.15 | 68.78 | 4.873M |
| Sep 17, 2026 | 70.64 | 71.05 | 68.92 | 69.92 | 1.398M |
| Sep 16, 2026 | 69.52 | 70.68 | 68.67 | 69.39 | 2.212M |
| Sep 15, 2026 | 72.13 | 72.19 | 68.55 | 69.31 | 2.577M |
| Sep 14, 2026 | 73.50 | 74.65 | 72.34 | 72.45 | 1.534M |
| Sep 11, 2026 | 74.66 | 75.98 | 73.50 | 73.77 | 1.722M |
| Sep 10, 2026 | 73.23 | 75.10 | 73.13 | 73.62 | 1.445M |
| Sep 09, 2026 | 74.31 | 74.89 | 73.52 | 74.11 | 1.425M |
| Sep 08, 2026 | 72.39 | 76.80 | 72.39 | 75.35 | 1.921M |
| Sep 04, 2026 | 73.04 | 74.01 | 72.26 | 72.72 | 1.141M |
| Sep 03, 2026 | 73.55 | 74.22 | 71.41 | 73.95 | 1.590M |
| Sep 02, 2026 | 71.90 | 73.70 | 70.42 | 71.93 | 1.606M |
| Sep 01, 2026 | 69.85 | 72.46 | 69.83 | 71.40 | 1.900M |
| Aug 31, 2026 | 71.54 | 71.79 | 69.31 | 70.91 | 3.078M |
| Aug 28, 2026 | 73.88 | 74.42 | 71.66 | 72.09 | 4.362M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bristol Myers Squibb Co. | 61.15 |
| Ionis Pharmaceuticals, Inc. | 43.54 |
| Vertex Pharmaceuticals, Inc. | 504.73 |
| Krystal Biotech, Inc. | 322.28 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
Price Related Metrics
| PS Ratio | 120.64 |
| PEG Ratio | -0.2214 |
| Earnings Yield | -11.01% |
| Market Cap | 9.103B |
| PEGY Ratio | -0.2214 |